Ning Jin

2.6k total citations · 1 hit paper
66 papers, 1.4k citations indexed

About

Ning Jin is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ning Jin has authored 66 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 18 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Ning Jin's work include PI3K/AKT/mTOR signaling in cancer (4 papers), Cancer-related Molecular Pathways (4 papers) and Cancer Genomics and Diagnostics (4 papers). Ning Jin is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (4 papers), Cancer-related Molecular Pathways (4 papers) and Cancer Genomics and Diagnostics (4 papers). Ning Jin collaborates with scholars based in China, United States and Pakistan. Ning Jin's co-authors include Barry D. Nelkin, Douglas W. Ball, Tianyun Jiang, Laith Abushahin, Carolyn J. Presley, Ashish Manne, Adithya Chennamadhavuni, Brendan Collins, Dina Rosen and D. Neil Watkins and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ning Jin

59 papers receiving 1.4k citations

Hit Papers

Risk Factors and Biomarkers for Immune-Related Adverse Ev... 2022 2026 2023 2024 2022 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ning Jin China 19 645 636 256 175 174 66 1.4k
Kun Yao China 22 492 0.8× 693 1.1× 348 1.4× 349 2.0× 262 1.5× 108 1.9k
Carmen Martínez‐García Spain 27 513 0.8× 431 0.7× 238 0.9× 124 0.7× 232 1.3× 62 2.0k
Qiushi Lin United States 21 595 0.9× 1.3k 2.1× 203 0.8× 338 1.9× 143 0.8× 38 2.3k
Bingjian Lü China 23 371 0.6× 786 1.2× 209 0.8× 511 2.9× 131 0.8× 83 1.7k
Kelly Huynh United States 17 479 0.7× 372 0.6× 135 0.5× 362 2.1× 82 0.5× 31 1.1k
Isaac S. Chan United States 15 322 0.5× 500 0.8× 412 1.6× 139 0.8× 62 0.4× 35 1.4k
Chia-Lung Tsai Taiwan 21 325 0.5× 844 1.3× 129 0.5× 272 1.6× 73 0.4× 73 1.5k
Peter Kaskel Germany 18 458 0.7× 541 0.9× 394 1.5× 180 1.0× 127 0.7× 43 1.5k
Ruty Mehrian‐Shai United States 21 242 0.4× 1.3k 2.0× 181 0.7× 294 1.7× 163 0.9× 43 2.2k
Marek Spaczyński Poland 23 567 0.9× 493 0.8× 436 1.7× 252 1.4× 104 0.6× 112 1.8k

Countries citing papers authored by Ning Jin

Since Specialization
Citations

This map shows the geographic impact of Ning Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning Jin more than expected).

Fields of papers citing papers by Ning Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ning Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning Jin. The network helps show where Ning Jin may publish in the future.

Co-authorship network of co-authors of Ning Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Ning Jin. A scholar is included among the top collaborators of Ning Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ning Jin. Ning Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maron, Steven B., Keisho Chìn, Fadi S. Braiteh, et al.. (2025). Phase II trial of enfortumab vedotin in patients with previously treated gastric and esophageal cancers. ESMO Open. 10(11). 105806–105806.
2.
Cao, Rui, Yu‐Rong Liu, Ning Jin, et al.. (2025). Genes related to neural tube defects and glioblastoma. Scientific Reports. 15(1). 3777–3777. 1 indexed citations
3.
Khan, Misbah, et al.. (2024). Riluzole Enhancing Anti-PD-1 Efficacy by Activating cGAS/STING Signaling in Colorectal Cancer. Molecular Cancer Therapeutics. 24(1). 131–140. 4 indexed citations
4.
Zhang, Shiqi, Ming Hu, Fouad Choueiry, et al.. (2024). Distinct plasma molecular profiles between early-onset and late-onset colorectal cancer patients revealed by metabolic and lipidomic analyses. Journal of Pharmaceutical and Biomedical Analysis. 241. 115978–115978. 2 indexed citations
6.
Hoyd, Rebecca, Ning Jin, Nicholas Denko, et al.. (2023). Exogenous Sequences in Tumors and Immune Cells (Exotic): A Tool for Estimating the Microbe Abundances in Tumor RNA-seq Data. Cancer Research Communications. 3(11). 2375–2385. 4 indexed citations
7.
Jin, Ning, Liang He, Haixia Jia, et al.. (2023). Spatiotemporal Patterns and Characteristics of PM2.5 Pollution in the Yellow River Golden Triangle Demonstration Area. Atmosphere. 14(4). 733–733. 1 indexed citations
8.
Ramsey, Mitchell L., Rachel Pearlman, Laith Abushahin, et al.. (2022). Mainstreaming germline genetic testing for patients with pancreatic cancer increases uptake. Familial Cancer. 22(1). 91–97. 23 indexed citations
9.
Jin, Ning, et al.. (2022). Polymerase Epsilon-Associated Ultramutagenesis in Cancer. Cancers. 14(6). 1467–1467. 13 indexed citations
10.
Ashraf, Muhammad Azeem, Samson Maekele Tsegay, & Ning Jin. (2021). Teaching Global Citizenship in a Muslim-Majority Country: Perspectives of Teachers from the Religious, National, and International Education Sectors in Pakistan. Religions. 12(5). 348–348. 12 indexed citations
11.
Fang, Jinbo, Gongmin Zhu, Yanli Zhu, et al.. (2020). Antitumor effects of apoptin expressed by the dual cancer-specific oncolytic adenovirus – a review. SHILAP Revista de lepidopterología. 5 indexed citations
12.
Jin, Ning, et al.. (2020). Spatiotemporal variation and determinants of population’s PM2.5 exposure risk in China, 1998–2017: a case study of the Beijing-Tianjin-Hebei region. Environmental Science and Pollution Research. 27(25). 31767–31777. 14 indexed citations
13.
Huo, Wei, Ning Jin, Fan Li, & Weihua Wang. (2013). MiRNA regulation of TRAIL expression exerts selective cytotoxicity to prostate carcinoma cells. Molecular and Cellular Biochemistry. 388(1-2). 123–133. 7 indexed citations
14.
Jin, Ning, Tianyun Jiang, David Rosen, Barry D. Nelkin, & Douglas W. Ball. (2011). Synergistic Action of a RAF Inhibitor and a Dual PI3K/mTOR Inhibitor in Thyroid Cancer. Clinical Cancer Research. 17(20). 6482–6489. 75 indexed citations
15.
Jin, Ning, Tianyun Jiang, Dina Rosen, Barry D. Nelkin, & Douglas W. Ball. (2009). Dual Inhibition of Mitogen-Activated Protein Kinase Kinase and Mammalian Target of Rapamycin in Differentiated and Anaplastic Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism. 94(10). 4107–4112. 66 indexed citations
16.
Jiang, Tianyun, Brendan Collins, Ning Jin, et al.. (2009). Achaete-Scute Complex Homologue 1 Regulates Tumor-Initiating Capacity in Human Small Cell Lung Cancer. Cancer Research. 69(3). 845–854. 149 indexed citations
17.
Nakakura, Eric K., Virote Sriuranpong, Muthusamy Kunnimalaiyaan, et al.. (2005). Regulation of Neuroendocrine Differentiation in Gastrointestinal Carcinoid Tumor Cells by Notch Signaling. The Journal of Clinical Endocrinology & Metabolism. 90(7). 4350–4356. 97 indexed citations
18.
Wan, Xiu‐Feng, Tao Ren, Ming Liao, et al.. (2005). Genetic characterization of H5N1 avian influenza viruses isolated in southern China during the 2003–04 avian influenza outbreaks. Archives of Virology. 150(6). 1257–1266. 32 indexed citations
19.
Jin, Ning. (2004). Evaluation of Binary Optics Manufacturing Parameters. Infrared Technology.
20.
Miao, Lin, Zhao Zhi-quan, Guozhong Ji, et al.. (2003). Expression of p16, cyclin D1 and RB protein in gastric carcinoma and premalignant lesions. Chinese Journal of Cancer Research. 15(1). 58–62.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026